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The Controversies in Breast Cancer 2008 meeting was held
at the Royal College of Physicians (Edinburgh, UK) on 1 to 2
September. It was the third such event and had the same
objective and format as the previous meetings. The objective
was to identify a discrete number of topical areas in breast
cancer that were either controversial in terms of being in
dispute or that merited debate in order to clarify issues
relating to obstacles to progress. To this end, an international
faculty of renowned experts was brought together to present
perspectives and debate them with an invited audience that
reflected a spectrum of disciplines and experience.
The basic brief of the faculty members was to identify the key
debating points in their allotted topic while being prepared to
‘fly some kites’ and be provocative. There was no need to
present methodology (unless it was an underlying cause of
uncertainty and conflict) or to incorporate unpublished results
(although they could be included, and novel interpretation of
existing data was most certainly encouraged). In certain
instances, individual speakers were asked to put one side of
a debate in order to allow another to present an opposing
view. All of these elements may be reflected in the
proceedings presented here; readers are asked to bear this
in mind when considering the texts.
Subject areas were chosen by the chairs. This year they
included the following: ‘What can surgeons do for us (and we
for them)?’; ‘Identification of personal risk to breast cancer’;
‘Endocrine therapy: where have we come from, where are we
at and where are we going?’; and ‘Optimizing the
implementation of future treatments - time to abandon
traditional methods’. There was also a debate on ‘Extended
follow up of breast cancer patients in the clinic wastes time
for both patients and doctors’.
It was poignant that the first session should have a surgical
basis. Tim Cooke was St Mungo Professor of Surgery at the
University of Glasgow. He was a strong supporter of the
Controversies meetings and would have been ever present
but for his untimely and tragic death in a road accident some
months earlier. The session and associated proceedings are
dedicated to his memory.
Because the intention of the meeting was to provoke debate,
a large amount of discussion followed the presentations. It
has not been possible to incorporate this into these
proceedings. However, the objective is not simply to provide
a paper record of the meeting. Instead, the hope is that the
texts are thought-inducing, will generate some novel
perspectives and will occasionally challenge established
dogma. In this way, we may achieve a better understanding of
some important problems relating to breast cancer.
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